TCL Archive ODAC Votes to Nix Amgen’s Drug Xgeva For Proposed Prostate Cancer Indication February 17, 2012
TCL Archive FDA Commissioner Mark McClellan tells NCI audience that science is far from eliminating cancer as a threat. February 6, 2004
TCL Archive New Seer Report Says Five Year Relative Survival At 49 Per Cent Over all, 50 Per Cent For White November 30, 1984
